National Health Investors stock gains 4.42 percent at EUR 59.00

Published on 10/20/2026 at 20:11 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

NHI will report third-quarter results on November 9, 2026. National Health Investors stock costs EUR 59.00, up 4.42 percent versus the Frankfurt close.

Price and reporting date

National Health Investors stock gained 4.42 percent at Lang & Schwarz on October 20, 2026.
NHI will publish third-quarter results on November 9, 2026.
National Health Investors stock costs EUR 59.00 at Lang & Schwarz on October 20, 2026 at 8:07 p.m. CEST, 4.42 percent above the Frankfurt close of October 19, 2026.
The company had a market capitalization of USD 3.2 billion and a 5.6 percent dividend yield.

NHI, US63633D1046, Illustration mit AI erstellt.

National Health Investors (ISIN US63633D1046) stock gained 4.42 percent against the Frankfurt close on October 20, 2026. National Health Investors will publish its third-quarter results after the market closes on November 9, 2026. The stock was trading at EUR 59.00 at Lang & Schwarz on October 20, 2026 at 8:07 p.m. CEST, 4.42 percent above the Frankfurt close of October 19, 2026.

November 9 sets the next test

The scheduled release covers the quarter ended September 30, 2026. The company will hold its results conference call on November 10, 2026, at 10:00 a.m. Eastern Time, according to the investor-relations release.

What does the valuation show?

National Health Investors had a market capitalization of USD 3.2 billion and a price-to-earnings ratio of 19.10 on October 20, 2026. Its 52-week range was USD 63.51 to USD 91.38, placing the latest NYSE quote of USD 66.06 at 2:10 p.m. ET near the lower end of that span.

The income picture includes a quarterly dividend of USD 0.92 and a 5.6 percent annualized yield, while fiscal-year 2026 earnings guidance stood at USD 4.74 to USD 4.79 per share, according to MarketBeat on October 3, 2026. The same report listed five buy ratings and four holds among nine analysts, with an average 12-month target of USD 82.25.

Comparison with peers

National Health Investors: up 2.10 percent on October 20, 2026, P/E 19.10, market capitalization USD 3.2 billion.

Omega Healthcare Investors (NYSE, USD): up 1.18 percent, P/E 16.22, market capitalization USD 13.8 billion.

Healthcare Realty Trust (NYSE, USD): up 3.39 percent, negative P/E, market capitalization USD 6.2 billion.

Senior housing remains central

National Health Investors specializes in healthcare real estate, including senior housing, skilled nursing facilities and medical office buildings. Investing.com reported on September 23, 2026 that BMO Capital maintained an Outperform rating and an USD 80.00 target. The report said senior housing operating properties represented 24 percent of assets, compared with 5 percent to 6 percent a year earlier.

Stock trades after hours

The move puts the euro quotation above the Frankfurt close used for the daily comparison, while the NYSE quote remains below the 52-week high of USD 91.38. The next scheduled result on November 9, 2026 is therefore the clearest dated operating checkpoint.

National Health Investors stock was trading at EUR 59.00 at Lang & Schwarz on October 20, 2026 at 8:07 p.m. CEST, 4.42 percent above the Frankfurt close of October 19, 2026. The further course of trading is shown by the continuously updated real-time quote of National Health Investors stock.